Search results for "capsid"

showing 10 items of 248 documents

Generation of multifunctional murine monoclonal antibodies specifically directed to the VP1unique region protein of human parvovirus B19.

2007

Little is known about the VP1unique region (VP1u), a part of one major capsid protein of human parvovirus B19 (B19), concerning its involvement in viral replication and infection cycle. Showing a phospholipase A2 (PLA2)-like activity, which is discussed to be necessary for viral release from host cell, its precise function remains unclear. The purpose of this study was to generate multifunctional monoclonal antibodies (mabs) for different applications that may be useful in investigating VP1u's relevance. To establish antiVP1u antibodies, spleen cells from Balb/c mice immunized with purified recombinant viral protein were used for generating antibody-producing hybridoma cell lines. Usability…

medicine.drug_classViral proteinPhospholipase A2 InhibitorsvirusesImmunologySpleenImmunofluorescenceMonoclonal antibodymedicine.disease_causeAntibodies Virallaw.inventionMicelawmedicineParvovirus B19 HumanImmunology and AllergyAnimalsHumansMice Inbred BALB Cbiologymedicine.diagnostic_testAntibodies MonoclonalHematologyVirologyMolecular biologyRecombinant ProteinsPhospholipases A2medicine.anatomical_structureCapsidViral replicationbiology.proteinRecombinant DNACapsid ProteinsAntibodyImmunobiology
researchProduct

Conformational and linear epitopes on virus-like particles of human papillomavirus type 33 identified by monoclonal antibodies to the minor capsid pr…

1995

The organization of epitopes on the minor capsid protein L2 of human papillomavirus (HPV) type 33 has been analysed using three monoclonal antibodies (MAbs) generated against a large fragment of the L2 protein (amino acids 82-259) expressed as a glutathione S-transferase fusion protein. The topology of the L2 epitopes has been investigated with respect to the structure of HPV-33 virus-like particles (VLPs). Two of the MAbs reacted with linear epitopes which were mapped to amino acids 153-160 and 163-170, respectively. These epitopes were accessible in denatured but not in native VLPs consisting of L1 and L2, suggesting an internal location. The third antibody was unable to detect denatured …

medicine.drug_classvirusesMolecular Sequence DataBiologyMonoclonal antibodyEpitopeEpitopesMiceCapsidAntigenAntibody SpecificityVirologymedicineAnimalsHumansAmino Acid SequenceAntigens ViralPapillomaviridaechemistry.chemical_classificationMice Inbred BALB CAntibodies Monoclonalvirus diseasesOncogene Proteins ViralUterine Cervical DysplasiaFusion proteinVirologyMolecular biologyAmino acidCapsidchemistryDNA Viralbiology.proteinCapsid ProteinsAntibodyEpitope MappingConformational epitopeJournal of General Virology
researchProduct

Immune status towards Epstein-Barr virus in a group of Sicilian children.

1989

The prevalence of antibodies to Epstein-Barr virus-determined antigens was studied in 17 children with acute infectious mononucleosis (IM) and in 263 children hospitalized for diseases unrelated to EBV infection. Antibodies against Epstein-Barr viral capsid antigens (VCA) were observed in 173 patients of the control group (66%), but 58 of them (33,5%) had not yet developed antibodies against Epstein-Barr virus-associated nuclear antigen (EBNA). IgM-specific antibodies were not found in any of the children of the control group but were present in all of the 17 patients with IM. The rates of positivity for IgA anti-VCA and IgG anti-early antigen (EA) were similar in all age groups. Anti-viral…

medicine.medical_specialtyHerpesvirus 4 HumanMononucleosisEpidemiologyFluorescent Antibody Techniquemedicine.disease_causeAntibodies ViralSerologyAntigenhemic and lymphatic diseasesEpidemiologymedicineHumansSerologic TestsInfectious MononucleosisChildAntigens ViralCell Nucleusbiologybusiness.industryAge FactorsInfant NewbornInfantmedicine.diseaseEpstein–Barr virusVirologyImmunoglobulin ATiterCapsidEpstein-Barr Virus Nuclear AntigensImmunoglobulin MItalyChild PreschoolImmunoglobulin GImmunologybiology.proteinAntibodybusinessEuropean journal of epidemiology
researchProduct

Induction of Type-Specific Neutralizing Antibodies by Capsomeres of Human Papillomavirus Type 33

2001

Abstract The immunogenicity of capsomeres of human papillomavirus type 33 was evaluated in a dose–response analysis. Capsomeres were obtained free of capsids by expression of L1 carrying the single point mutation C427S. Neutralizing antibodies were detected using an in vitro pseudoinfection assay. Capsomeres induced type-specific, neutralizing antibodies in mice even in the absence of adjuvant. The neutralization titers of immune sera raised without adjuvant were 10- to 20-fold lower than those of antisera to virus-like particles, but virtually identical using Freund's adjuvant. These data indicate that capsomeres may substitute for virus-like particles in future vaccines when used with an …

medicine.medical_treatmentDose-Response Relationship ImmunologicEnzyme-Linked Immunosorbent AssayAntibodies ViralpapillomavirusNeutralizationMiceCapsidNeutralization Testsdose responseVirologymedicineAnimalsHumansPapillomaviridaeAntiserumMice Inbred BALB CbiologyImmunogenicityCapsomereVirionneutralizationvaccinationVirologyTiterCapsidbiology.proteincapsomeresImmunizationAntibodyAdjuvantVirology
researchProduct

Cytoplasmic parvovirus capsids recruit importin beta for nuclear delivery

2020

Parvoviruses are an important platform for gene and cancer therapy. Their cell entry and the following steps including nuclear import are inefficient limiting their use in therapeutic applications. Two models exist on parvoviral nuclear entry: classical import of the viral capsid using nuclear transport receptors of the importin (karyopherin) family, or direct attachment of the capsid to the nuclear pore complex leading to local disintegration of the nuclear envelope. Here, by laser scanning confocal microscopy and in situ proximity ligation analysis combined with co-immunoprecipitation we showed that infection requires importin β-mediated access into the nuclear pore complex and nucleopori…

nucleoplasmkaryoferiinitsolulimatumaimportin βcytoplasminteractionparvoviruksetParvovirus capsidkapsidi
researchProduct

Evidence for Positive Selection in the Capsid Protein-Coding Region of the Foot-and-Mouth Disease Virus (FMDV) Subjected to Experimental Passage Regi…

2001

We present sequence data from two genomic regions of foot-and-mouth disease virus (FMDV) subjected to several experimental passage regimens. Maximum-likelihood estimates of the nonsynonymous-to-synonymous rate ratio parameter (dN/dS) suggested the action of positive selection on some antigenic sites of the FMDV capsid during some experimental passages. These antigenic sites showed an accumulation of convergent amino acid replacements during massive serial cytolytic passages and also in persistent infections of FMDV in cell culture. This accumulation was most significant at the antigenic site A (the G-H loop of capsid VP1), which includes an Arg-Gly-Asp (RGD) cellular recognition motif. Our …

parallel evolutionmedicine.drug_class[SDV]Life Sciences [q-bio]virusesMolecular Sequence DataPopulationMonoclonal antibodyVirusEvolution Molecular03 medical and health sciencesAphthovirusCapsidAntigenpositive selectionGeneticsmedicineCoding regionSelection GeneticSerial Passageconvergent evolutioneducationMolecular BiologyPhylogenyEcology Evolution Behavior and Systematics030304 developmental biologychemistry.chemical_classification0303 health scienceseducation.field_of_studyModels GeneticbiologyFoot-and-mouth disease virusfoot-and-mouth disease virusexperimental phylogeny030306 microbiologyParallel evolutionbiochemical phenomena metabolism and nutritionbiology.organism_classificationVirology3. Good healthAmino acidPositive selection[SDV] Life Sciences [q-bio]CapsidchemistryFoot-and-mouth disease virusExperimental phylogenyConvergent evolutionMolecular Biology and Evolution
researchProduct

Recombinant nanocapsid for targeted theranostic delivery

2017

Developments in diagnostic and therapeutic delivery are trending towards molecular level targeting with nano-platforms. Targeted delivery reduces generalized distribution by localizing diagnostic and/or therapeutic (theranostic) molecules to an intended target site. The first section of this thesis proposes Hepatitis E Virus (HEV) nanocapsids as a vector to stabilize and target theranostic delivery. Derived from the capsid protein of HEV, a feco-orally transmitted virus, HEV-like particles self-assemble in to non-infectious, nanocapsids that can withstand harsh protease and pH conditions in the mucosal system. The flexible nanocapsid surface protrusion domain is amenable to substantial modi…

theranosticshepatiitti E -virusviruksetenterovirustargeted deliverybioconjugationyksilöity lääkehoitonanolääketiedekultaenteroviruksetnanocapsidkemialliset sidoksetgold nanoclusterhepatiittiviruksetencapsulationnanohiukkasetkapsidi
researchProduct

Experimental Evolution Reveals a Genetic Basis for Membrane-Associated Virus Release

2021

Many animal viruses replicate and are released from cells in close association to membranes. However, whether this is a passive process or is controlled by the virus remains poorly understood. Importantly, the genetic basis and evolvability of membrane-associated viral shedding have not been investigated. To address this, we performed a directed evolution experiment using coxsackievirus B3, a model enterovirus, in which we repeatedly selected the free-virion or the fast-sedimenting membrane-associated viral subpopulations. The virus responded to this selection regime by reproducibly fixing a series of mutations that altered the extent of membrane-associated viral shedding, as revealed by fu…

ultra-deep sequencingUltra-deep sequencingvirusesMutagenesis (molecular biology technique)Viral transmissionBiologyAcademicSubjects/SCI01180Virus03 medical and health sciencesGeneticsViral sheddingdirected evolutionMolecular BiologyEcology Evolution Behavior and SystematicsDiscoveriesEnterovirus030304 developmental biology0303 health sciencesExperimental evolution030306 microbiologyenterovirusviral transmissionAcademicSubjects/SCI01130Directed evolutionVirologyvirus–membrane interactionsBiological EvolutionVirus ReleaseVirus–membrane interactions3. Good healthEnterovirus B HumanVirus SheddingEvolvabilityCapsidAmino Acid SubstitutionDirected evolutionCapsid ProteinsGenetic FitnessMolecular Biology and Evolution
researchProduct

Soft X-ray Tomography Reveals HSV-1-Induced Remodeling of Human B Cells.

2022

Upon infection, viruses hijack the cell machinery and remodel host cell structures to utilize them for viral proliferation. Since viruses are about a thousand times smaller than their host cells, imaging virus-host interactions at high spatial resolution is like looking for a needle in a haystack. Scouting gross cellular changes with fluorescent microscopy is only possible for well-established viruses, where fluorescent tagging is developed. Soft X-ray tomography (SXT) offers 3D imaging of entire cells without the need for chemical fixation or labeling. Here, we use full-rotation SXT to visualize entire human B cells infected by the herpes simplex virus 1 (HSV-1). We have mapped the temporo…

viruksetisäntäsolutBioengineeringmikroskopiainfektiotMicrobiologyX-ray tomography; soft X-rays; infection imaging; HSV-1; cell mapping; cryo imagingherpes simplex -virusCapsidsoft X-raystomografiaVirologyHumans2.2 Factors relating to the physical environment2.1 Biological and endogenous factorsAetiologyherpesviruksetTomographycryo imagingHerpesvirus 1herpesinfection imagingHSV-1solutInfectious Diseasesröntgenkuvauscell mappingX-RaySexually Transmitted InfectionsInfectionX-ray tomographysolubiologiaHuman
researchProduct

An ancient virus type from extreme environments

2014

virus evolutionbacteriophage P23-77rakenneviruksetääriolosuhteetrakentuminenkuoriproteiinitsukulaisuussuhteetsukulaisuusvirus capsid assemblybakteriofagi P23-77viral lineageproteiinikuorivirus capsid proteinskapsidi
researchProduct